GLP-1 Weight loss for a lifetime.

Results in a New York minute.

Medical weight loss in New York State.

Accessible online.

Science backed GLP-1, compounded Semaglutide/Ozempic® & Tirzepatide/Mounjaro®

Am I Eligible?

Finally, weight loss that lasts a lifetime.

The secret your fit friends already know. GLP-1 medications like Semaglutide (Ozempic®/Wegovy®) and Tirzepatide (Zepbound® Mounjaro®) are superior for weight loss and the weight stays off when taken long-term!

Weight loss without the cost.

The cost of commercial pharmacy GIP & GLP-1s can make it hard to keep up with weight loss maintenance. Luckily, you don’t need them.

If you’re eligible and living in New York State, we’ve got you covered at below retail pricing.

Safe, effective, convenient care.

We provide high quality GLP-1 Semaglutide (the active ingredient in Ozempic®/Wegovy®) and Tirzepatide (the active ingredient in Zepbound®/Mounjaro®), and non-medical weight loss programs in New York State. All conveniently via telehealth. Our medical weight loss products are prescribed through regulated, sterile compounding pharmacies, priced for long-term use, and delivered directly to your home.

Am I Eligible?

Two beautiful women who have lost weight using GLP-1s, semaglutide, and tirzepatide at Omni Health NP.

Medications provide the advantage but let’s be real…

Nutrition and exercise matter. Our experts can help you get this right. All inclusive.

WEIGHT LOSS IN NEW YORK STATE

Medications have side effects and some clinics abandon their clients! We prevent, control, and treat side effects tailored for you.

WEIGHT LOSS IN NEW YORK STATE

Gut health is important for weight loss! We use food and supplements to balance gut bacteria, manage food cravings, and improve your overall health.

gut bacteria new york state

With the right help, success is possible for everyone.

Weight Loss in New York State

We Proudly Serve the State of New York

GLP-1s, semaglutide, and tirzepatide at Omni Health NP.

Join the countless New York residents who have reached their weight loss goals safely and effectively with our medically supervised weight loss plans.

A woman who is struggling with hormonal weight gain but making progress with GLP-1s, semaglutide, and tirzepatide at Omni Health NP.

Overcome stubborn weight gain caused by your lifestyle or hormones. The experts are here to support you every step of the way.

Quality care with GLP-1s, semaglutide, and tirzepatide at Omni Health NP.

At Òmni Health NP, we pride ourselves on providing quality care and getting you results. See what some of our patients have to say about us below!

Testimonials

Also check out our reviews on Google and Trustpilot


“After struggling with my weight for years, Omni Health NP finally helped me achieve my goals. The personalized care and attention to detail were unparalleled. I feel healthier, more confident, and more energized than ever before.”
An older triumphant woman who has finally lost weight and is now fit and healthy with GLP1 semaglutide and tirzepatide.
J. D. Bedford, NY

“I can’t believe how quickly I saw results. In just three months, I lost 16 pounds and transformed my lifestyle. The personalized plan and holistic support from Omni Health NP were the keys to my success.”
A younger triumphant woman who has finally lost weight and is now fit and healthy with GLP1 semaglutide and tirzepatide.
D. C.New Rochelle, NY

“The last three months have been incredible. I lost 24 pounds and gained a new outlook on life. The team at Omni Health NP provides exceptional care and support, making the process enjoyable and effective.”
A triumphant woman who has finally lost weight and is now fit and healthy with GLP1 semaglutide and tirzepatide.
S. C.White Plains, NY

Based on randomized control trials the average weight loss with semaglutide over 20 weeks was 10.9% of baseline body weight with increased and sustained weight loss over 52 weeks [1]. Two randomized trials in adults with obesity demonstrated mean losses of 15 to 21% body weight with the highest dose of tirzepatide (15 mg weekly) over 72 weeks but weight loss was observed at every dose level [2].

Get the e-book: “Can’t Wait for Goal Weight“: How to Lose Fat, Gain Muscle, and Fall in Love with your BMI by Dr. Shatika James, DNP

A $20 value, FREE for clients of Òmni Health NP.

A necessary addition to every weight loss plan. This e-book gives you everything you need to lose fat and keep it off for good, with or without medications! Find answers to questions like:

How can I lose fat without medications?

“How can I prevent weight REGAIN?”

“How can I overcome weight stalls?”

“How do I stop using GIP/GLP-1 medications without gaining the weight back?

“What can I do if I stop responding to the medication?”

At Òmni Health NP, you are never left to fend for yourself. Not only are our medical providers (real humans!) available via text for questions and guidance, but we have developed a comprehensive e-book to help you recognize weight regain and how to counter it.

There are also juicy bits about how you should eat to enhance the effects of your GIP/GLP-1 RA and how to manage lesser-known side effects of these medications, like hair loss.

Even if you decide not to take advantage of our exceptional weight loss services, this book is for you! *Knowledge is Power* Find out how to finally reach your goal weight and enjoy your healthy, new life!

Compounded Medication Pricing

Compounded Semaglutide: 4-week supply

All orders include medical visit, prescription, all supplies, & free shipping.

GLP-1 RA LEARN MORE

Am I Eligible?

Initial dosage .25 mg/week up to .50 mg/week ($350 total)

.75 mg/week ($375 total)

1 mg/week ($415 total)

1.7 mg/week ($493 total)

2 mg/week ($530 total)

2.5 mg/week ($593 total)

Compounded Tirzepatide: 4-week supply

All orders include medical visit, prescription, all supplies, & free shipping.

GIP/GLP-1 RA LEARN MORE

Am I Eligible?

Initial dosage 2.5 mg/week ($350 total)

5 mg/week ($470 total)

7.5 mg/week ($550 total)

10 mg/week ($600 total)

12.5 mg/week ($650 total)

15 mg/week ($700 total)

Getting Started is Easy!

Check your eligibility by clicking the “Am I Eligible?” buttons on the page and filling out the form. We will contact you via email if you are eligible for our plans and provide a link for purchase, lab orders if necessary, and your telehealth appointment. Schedule an appointment date that allows for bloodwork if you haven’t had blood drawn within the last year.

Complete HIPAA compliant medical forms (sent via email) detailing family and medical history, current medications, prior weight loss attempts, upload ID and lab results. Obtain blood work prior to your telehealth visit to avoid delays in prescriptions.

Meet with your medical provider. Discuss your intake form, lab results, and all options for medical weight loss. Then, obtain your prescriptions, if appropriate.

Receive your scheduled medication in the mail directly from the compounding pharmacy.

This is just the beginning of a beautiful relationship! We continue to follow up with your progress and make adjustments as needed.

Compounded medications are a safe and effective alternative to brand name medications.

Patients taking compounded medications get similar results as those taking commercial formulations.

Per the Obesity Medicine Association statement “…compounding pharmacies are regulated by State Boards of Pharmacy and expected to comply with Current Good Manufacturing Practice (CGMP) requirements and may receive compounding accreditation… clinicians should verify safeguards such that the source anti-obesity medications and their formulations have undergone adequate clinical trial testing for efficacy and safety.”

At Òmni Health NP, we vet our compounding pharmacies for good standing with their State Board of Pharmacy and the FDA.

The FDA-approved brand name drugs, such as Saxenda®, Victoza®, Wegovy®, and Ozempic® are exclusively available from the Novo Nordisk™ company. Mounjaro® and Zepbound™ are exclusively available from Eli Lilly and Company™ and can be obtained commercially.

Òmni Health NP does not claim any affiliation with, or endorsement from, the above-mentioned products or entities. We do not offer non-compounded products unless insurance is used to obtain it commercially. Anyone seeking said products should discuss options with their licensed healthcare provider or pharmacist. Òmni Health NP exclusively offers compounded medications, which are made in State Board of Pharmacy licensed sterile compounding pharmacies, or FDA-licensed 503(b) Outsourcing Facilities. While these facilities are strictly regulated, the compounded medications they make are not FDA-approved, as they are compounded based on an individual provider’s prescription for a specified patient. Strength, dose, route of administration, and other variables may make compounded medications different from FDA-approved drugs which makes directly comparing results & risk profile between FDA-approved drugs and compounded drugs difficult. Any compounded drugs prescribed are based on a licensed provider’s medical judgement based on a telehealth encounter and medical history.

Am I Eligible?

† Ozempic®, WeGovy®, Saxenda®, and Victoza® are registered trademarks of Novo Nordisk. Zepbound® and Mounjaro® are registered trademarks of Eli Lilly. Òmni Health NP is not affiliated with Novo Nordisk or Eli Lilly, and the compounded products offered by Òmni Health NP are not produced by these companies. Compounded medications may be prescribed based on personal weight loss needs. While federal law allows the prescription of compounded drugs, they are not FDA-approved and do not undergo safety, effectiveness, or manufacturing review.

The information provided on this website is for informational purposes and not a substitute for professional medical advice, diagnosis, or treatment. If you have questions or concerns about your health, please talk to your medical provider. This site is an advertisement for services and not any specific medication.

[1] Rubino D, Abrahamsson N, Davies M, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. 2021;325(14):1414–1425. doi:10.1001/jama.2021.3224

[2] Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomized, multicenter, placebo-controlled, phase 3 trial. Lancet 2023; 402:613.